Showing results (1181-1190 of 1,557) with videos related to

Sort By:
Pageof 156
Clinical Lymphoma, Myeloma & Leukemia|January 21, 2026
Relative Effectiveness of Talquetamab Versus Real-World Physician's Choice Treatment Regimens in Patients With Relapsed/Refractory Multiple Myeloma: Updated Results From an Indirect Treatment ComparisonJing Christine Ye, Noa Biran, Sandhya Nair, et al.
Journal of Virology|March 11, 2011
The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infectionElin S Gray, Maphuti C Madiga, Tandile Hermanus, et al.
Neurology. Clinical Practice|September 6, 2021
Depressive Symptoms and Risk of Stroke in a National Cohort of Black and White Participants From REGARDSCassandra D Ford, Marquita S Gray, Martha R Crowther, et al.
The Journal of Molecular Diagnostics : JMD|January 7, 2018
Droplet Digital PCR for Mutation Detection in Formalin-Fixed, Paraffin-Embedded Melanoma Tissues: A Comparison with Sanger Sequencing and PyrosequencingAshleigh C McEvoy, Benjamin A Wood, Nima M Ardakani, et al.
Plos Pathogens|September 2, 2022
Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodiesCathrine Scheepers, Prudence Kgagudi, Nonkululeko Mzindle, et al.
Cell Chemical Biology|April 23, 2016
GNF-2 Inhibits Dengue Virus by Targeting Abl Kinases and the Viral E ProteinMargaret J Clark, Chandra Miduturu, Aaron G Schmidt, et al.
Advanced Healthcare Materials|September 23, 2025
Visible Light Induced DLP-Printed Oxygen-Releasing TPMS Scaffolds Mitigate Early Hypoxia in Bone DefectsAnastasia B Timoshenko, Ali Ghasemkhani, Chanul Kim, et al.
Angewandte Chemie (International Ed. in English)|May 17, 2020
Development of CDK2 and CDK5 Dual Degrader TMX-2172Mingxing Teng, Jie Jiang, Zhixiang He, et al.
Journal of the American Chemical Society|November 26, 2025
Development of FBXO22 Degraders and the Recruitment Ligand 2-Pyridinecarboxyaldehyde (2-PCA)Tian Qiu, Zhe Zhuang, Woong Sub Byun, et al.
Transfusion Medicine (Oxford, England)|March 1, 1997
A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactionsN A Anderson, S Gray, J A Copplestone, et al.
Pageof 156